SEC Company Response from Medigus Ltd. (XYLO) (CIK 0001618500) — May 5, 2020
Medigus Ltd. (XYLO) (CIK 0001618500)
Date: May 5, 2020 · CIK: 0001618500 · Accession: 0001213900-20-010985
AI Filing Summary & Sentiment
File numbers found in text: 333-237774
Show Raw Text
CORRESP
1
filename1.htm
May 5, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Division of Corporation Finance,
Office of Life Sciences
VIA EDGAR
Re: Medigus Ltd. (the “Company”)
Registration Statement on Form F-3
(the “Registration Statement”)
Filed on April 21, 2020
File No. 333-237774
Dear Madam or Sir:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, the Company respectfully requests that the effectiveness of the registration statement
on Form F-3 (File No. 333-237774) of the Company (the “Registration Statement”) be accelerated so that the Company’s
Registration Statement will become effective at 04:00 p.m., Eastern Time, on May 5, 2020 or as soon thereafter as may be practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by email to our counsel, Meitar Law Offices, by
emailing Dr. Shachar Hadar, Esq. at shacharh@meitar.com and Jonathan M. Nathan, Esq. at jonathann@meitar.com.
Sincerely,
/s/ Liron Carmel
Liron Carmel
Chief Executive Officer
Medigus Ltd.